Urinary Metabolomic Characterization of Meclofenoxate Based on UHPLC-Q Exactive HF Orbitrap MS Technology
The Analyst · 2026
DOI: 10.1039/d5an01344e ↗Kurz gefasst
Fachartikel in der Zeitschrift The Analyst, 2026. Verfasst von Bing Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Doping Control, Shanghai University of Sport, 399 Changhai Road, Shanghai 200438, China. liubing2019@sus.edu.cn. Hauptthemen laut MEDLINE: Metabolomics.
Abstract (Originalsprache)
To investigate the characteristics of changes in human urine metabolites of meclofenoxate by using metabolomics technology based on ultra performance liquid chromatography-Q Exactive HF Orbitrap mass spectrometry (UHPLC-Q Exactive HF...
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Institute for Doping Control, Shanghai University of Sport, 399 Changhai Road, Shanghai 200438, China. liubing2019@sus.edu.cn.
- School of Life Sciences, Shanghai University, Shanghai 200444, China.
Zitieren
APA
Liu, B., Xu, W., Zheng, T., Li, Z., & Zhao, J. (2026). Urinary Metabolomic Characterization of Meclofenoxate Based on UHPLC-Q Exactive HF Orbitrap MS Technology. The Analyst. https://doi.org/10.1039/d5an01344e
Vancouver
Liu B, Xu W, Zheng T, Li Z, Zhao J. Urinary Metabolomic Characterization of Meclofenoxate Based on UHPLC-Q Exactive HF Orbitrap MS Technology. The Analyst. 2026. doi:10.1039/d5an01344e
BibTeX
@article{Liu2026,
author = {Liu, Bing and Xu, Wennuo and Zheng, Tingyuan and Li, Zhongquan and Zhao, Jingjing},
title = {Urinary Metabolomic Characterization of Meclofenoxate Based on UHPLC-Q Exactive HF Orbitrap MS Technology},
journal = {The Analyst},
year = {2026},
doi = {10.1039/d5an01344e}
}
EUVIMED